Stocktoria
Hinge Health, Inc. HNGE
NYSE · stock · Services-Computer Processing & Data Preparation · website · IPO 2025-05-22
Hinge Health, Inc. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $587.9M | $390.4M |
| Gross profit | $468.2M | $299.9M |
| R&D expense | $368.1M | $100.8M |
| Operating income | -$546.4M | -$31.9M |
| Income tax | $998,000 | $677,000 |
| Net income | -$528.3M | -$11.9M |
| EPS (diluted) | $-7.77 | $-0.88 |
| Operating cash flow | $171.4M | $49.0M |
| Free cash flow | $170.7M | $48.0M |
| Cash & equivalents | $208.0M | $300.8M |
| Inventory | $15.6M | $10.9M |
| Total assets | $744.8M | $673.3M |
| Total liabilities | $366.2M | $256.6M |
| Shareholders' equity | $178.7M | -$434.6M |
Growth · year-over-year · Revenue CAGR 50.6%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | +50.6% | — |
| Free cash flow growth | +256.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.